688166.SS
688166.SS
CNE100003PR1
BRIGHTGENE BIO-MEDICAL TECHNOLO
Loading chart...

Company Profile

-

Related stocks

9606.HK
9606.HK • China
DUALITYBIO-B
182.7 HKD
2.13B USD 1Y -42.1%
002287.SZ
002287.SZ • China
CHEEZHENGTTM
19.56 CNY
1.67B USD 1Y -24.9%
300009.SZ
300009.SZ • China
ANKEBIO
8.53 CNY
2.13B USD 1Y -17.1%
2595.HK
2595.HK • China
GENFLEET-B
28.6 HKD
1.4B USD 1Y -21%
301301.SZ
301301.SZ • China
CN BIO
8.22 CNY
2.75B USD 1Y -24.9%
688382.SS
688382.SS • China
INVENTISBIO CO LTD
17.26 CNY
1.5B USD 1Y -42.5%
1952.HK
1952.HK • China
EVEREST MED
29.6 HKD
1.33B USD 1Y -47.1%
300255.SZ
300255.SZ • China
CHANGSHAN PHARMA
22.15 CNY
3.05B USD 1Y -55.1%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
4 Metrics
Country

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
59.3% p.a.
Max Drawdown (5Y)
-74.7%
Sharpe Ratio (5Y)
0.01
Beta Factor
0.19
Size Class
Large Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
🔴 High valuation risk: Avg P/E of 145.8 (Elevated multiple compression risk)
Elevated Short-Term Volatility: 3Y volatility (66.4%) is noticeably higher than the 5Y average (59.3%).
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (59.3% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -74.7% in the extended horizon.
ende